HOF Pharma targets global expansion
Currently HOF is exporting to 12 countries across Latin America, Africa, and Southeast Asia.
Author
Non-injectable medication development remains significant unmet need in female infertility:…
The development of non-injectable fertility medications represents a significant unmet need, according to key opinion leaders…
Malay Vyas appointed President & Business Head of STEER America
Vyas aims to play a key role in shaping the strategic direction, fostering innovation & leading long-term growth and…
APIC and GFI India collaborate, aim to reshape India’s smart protein landscape
GFI India and APIC sign an MoU to propel advancements in smart protein innovation, scale-up, and market penetration throughout…
India’s pharmaceutical logistics sector: navigating challenges, solution and seizing…
India's pharmaceutical industry is on a promising path, with a vision to reach a staggering $130 billion by 2030 and $450 billion…
A comprehensive approach to certification, quality control, and consumer trust in nutraceuticals
Nutraceuticals are a promising alternative for people seeking natural ways to enhance their overall quality of life.
Innovent Biologics mazdutide can pave way for transformative T2D treatment: GlobalData
Mazdutide will be the second drug from Innovent Biologics in Chinese metabolic disorders market
Biocon partners with Handok to commercialise Liraglutide in South Korea
Biocon to develop and supply Liraglutide; Handok to handle regulatory approval and commercialisation in South Korea.
Taro shareholders approve merger with Sun Pharma
Upon the completion of merger Taro will become a privately held company wholly owned by Sun Pharma
Pharma companies urged to act on antimicrobials to combat drug resistance
New report highlights urgent need for better access and stewardship in developing new antibiotics.